GlassScriptPhysician profile
Richard K Ryu
NPI 1356366488
$322,603.15
in general payments reported to CMS, 2019-2025
20 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117K · 2020: $88K · 2021: $20K · 2022: $55K · 2023: $13K · 2024: $19K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,800 · Travel and Lodging: $2,629 · Food and Beverage: $2,137 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,842.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,800.00 |
| Travel and Lodging | $2,628.56 |
| Food and Beverage | $2,136.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,725.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $172,087.71 | 2019-2025 | Bioknotless Ethibond, Quickanchor Orthocord, Mitek |
| Smith+Nephew, INC. | $117,507.85 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Mini-Open Latarjet, Healicoil |
| Depuy Synthes Products, INC. | $23,829.50 | 2019-2025 | Bioknotless Ethibond, Quickanchor Orthocord, Fms |
| Linvatec Corporation | $4,861.24 | 2023-2025 | Biobrace 23mm |
| Miach Orthopaedics, INC. | $2,007.52 | 2021-2023 | |
| Arthrex, INC. | $523.23 | 2023-2024 | Arthrex |
| Depuy Synthes Sales INC. | $522.56 | 2019-2024 | Healix Knotless Peek |
| Pacira Therapeutics, INC. | $509.99 | 2019-2021 | |
| Cornerstone Medical Associates, INC. | $176.53 | 2024-2025 | |
| Medacta USA, INC. | $117.55 | 2020 | |
| Curonix LLC | $90.17 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Zimvie INC. | $73.25 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $69.09 | 2024 | Exparel, Zilretta |
| Dynasplint Systems INC. | $65.24 | 2025 | Dynasplint |
| Djo, LLC | $53.33 | 2023-2024 | Procare, Aircast, Donjoy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $40.57 | 2024 | Citrefix |
| Orthofix Medical, INC. | $19.55 | 2023 | Physio-Stim, Spinal-Stim |
| Fidia Pharma USA INC. | $17.56 | 2019-2022 | |
| Alafair Biosciences, INC. | $15.40 | 2024 | Versawrap |
| Avanos Medical | $15.31 | 2023 | Trivisc Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ryu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.